GRNA
GreenLight Biosciences Holdings
$0.30
%
Analyst Rating:Buy

Stock Details

CEO

Andrey Juan Zarur

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

280

Address

200 Boston Avenue, Medford, MA, 02155

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for GreenLight Biosciences Holdings  $0.30

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: GRNA